<DOC>
	<DOC>NCT00858637</DOC>
	<brief_summary>The primary objective of this study is to demonstrate the superiority of MCI-196 over placebo and non-inferiority with simvastatin in reducing serum low-density lipoprotein (LDL)-cholesterol in subjects with chronic kidney disease Stage V on dialysis. This study incorporates a Washout Period and two treatment periods - an active comparison phase and a placebo-controlled withdrawal phase.</brief_summary>
	<brief_title>Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Bile Acids and Salts</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Male or female, and is &gt;=18 years old Stable hemodialysis or peritoneal dialysis Subjects undergoing regular dialysis treatment If Female and of childbearing potential, have a negative serum pregnancy test Male subjects must agree to use appropriate contraception Current clinically significant medical comorbidities, which may substantially compromise subject safety, or expose him/her to undue risk, or interfere significantly with study procedures and which, in the opinion of the Investigator, makes the subject unsuitable for inclusion in the study Serum albumin level &lt; 30 g/L Triglycerides level &gt; 6.76 mmol/L (600 mg/dL) LDLcholesterol level &gt; 4.94 mmol/L (190 mg/dL) A History of significant gastrointestinal motility problems Biliary obstruction or proven liver dysfunction A positive test for HIV 1 and 2 antibodies A history of substance or alcohol abuse within the last year The subject has a history of rhabdomyolysis or myopathy Schedule to receive a kidney transplant within the next 6 months The subject has porphyria Participation in a clinical study with any experimental medication in the last 30 days or an experimental biological product within the last 90 days prior to signing of informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Bile acid sequestrant</keyword>
</DOC>